Christopher E. Goldring
- Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection 27
- Pharmacogenetics and Drug Metabolism 17
- Hepatology top 0.5%
- Liver physiology and pathology 20
- Molecular Biology top 2%
- Genomics, phytochemicals, and oxidative stress 30
- Glutathione Transferases and Polymorphisms 20
- Pluripotent Stem Cells Research 10
- Cancer Research top 2%
- MicroRNA in disease regulation 9
- Biochemistry top 2%
-
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Neil R. KitteringhamB. Kevin ParkT.M.A. OlayanjuIan M. CoppleRosalind E. JenkinsDaniel J. AntoineJames W. DearJoanne Walsh
- Journals
- Hepatology (9 papers)Scientific Reports (5 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Christopher E. Goldring
119 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Pharmacology 1.5k
- Hepatology 1.1k
- Molecular Biology 3.8k
- Cancer Research 814
- Biochemistry 198
Countries citing papers authored by Christopher E. Goldring
This map shows the geographic impact of Christopher E. Goldring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Goldring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Goldring more than expected).
Fields of papers citing papers by Christopher E. Goldring
This network shows the impact of papers produced by Christopher E. Goldring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Goldring. The network helps show where Christopher E. Goldring may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher E. Goldring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2018 | 24 | |
| 12 | 2018 | 19 | |
| 13 | 2015 | 44 | |
| 14 | 2015 | 25 | |
| 15 | 2014 | 25 | |
| 16 | Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospitalbreakdown → | 2013 | 328 |
| 17 | 2012 | 77 | |
| 18 | 2011 | 2 | |
| 19 | 2010 | 48 | |
| 20 | 2007 | 50 |
About Christopher E. Goldring
Christopher E. Goldring is a scholar working on Pharmacology, Hepatology and Cancer Research, having authored 124 papers that have together received 7.1k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (30 papers), Drug-Induced Hepatotoxicity and Protection (27 papers), Liver physiology and pathology (20 papers), Glutathione Transferases and Polymorphisms (20 papers), Pharmacogenetics and Drug Metabolism (17 papers), Pluripotent Stem Cells Research (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Pharmacology (1.5k citations), Hepatology (1.1k citations) and Molecular Biology (3.8k citations). Christopher E. Goldring has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Neil R. Kitteringham, B. Kevin Park, T.M.A. Olayanju, Ian M. Copple, Rosalind E. Jenkins, B. Kevin Park, B. Kevin Park, Daniel J. Antoine, James W. Dear and Joanne Walsh. Their work appears in journals such as Hepatology, Scientific Reports, Journal of Biological Chemistry, British Journal of Clinical Pharmacology and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.